An IL-13 inhibitor blocks the development of hepatic fibrosis during a T-helper type 2–dominated inflammatory response
Open accessThe DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
Abstract
In schistosomiasis, chronic parasite egg-induced granuloma formation can lead to tissue destruction and fibrosis, which causes much of the morbidity and mortality associated with this disease. Here we show the importance of IL-13 in the pathogenesis of schistosomiasis, and demonstrate, perhaps for the first time, the therapeutic efficacy of an IL-13 inhibitor, sIL-13Ralpha2-Fc, in the control of hepatic fibrosis. T-helper type 2 (Th2) cytokines dominate the immune response in mice infected with Schistosoma mansoni, yet the specific contributions of IL-13 and IL-4 to the development of fibrosis were not previously investigated. Our studies demonstrate that both cytokines play redundant roles in granuloma formation, which explains the ability of IL-4-deficient mice to form granulomas around eggs. More importantly, however, these studies demonstrate that IL-13 is the dominant Th2-type cytokine regulating fibrosis. IL-13 stimulated collagen production in fibroblasts, and procollagen I and procollagen III mRNA expression was decreased in sIL-13Ralpha2-Fc-treated mice. Moreover, the reduction in fibrosis observed in IL-4-deficient mice was much less pronounced than that in sIL-13Ralpha2-Fc-treated animals. Fibrosis is a major pathological manifestation of a number of allergic, autoimmune, and infectious diseases. Thus, our findings provide evidence that IL-13 inhibitors may be of general therapeutic benefit in preventing damaging tissue fibrosis resulting from Th2-dominated inflammatory responses.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“IL-11, a member of the IL-6/gp130 cytokine family, may be one such target as it was recently shown to integrate pro-fibrotic signals emanating from both pathways146–149”
From Fibrosis: from mechanisms to medicines (2020) · cites this paper as [147]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Interleukin-13: Central Mediator of Allergic Asthma
Wills-Karp, M., Luyimbazi, J., Xu, X., Schofield, B., Neben, T. Y., Karp, C. L., & Donaldson, D. D. (1998) · Science · doi:10.1126/science.282.5397.2258 · Cited by 2,617 · cited 2×
“IL-13 was also recently shown to play a central role in murine asthma (30, 31).”
BackgroundSelf-citationRequirement for IL-13 Independently of IL-4 in Experimental Asthma
Grünig, G., Warnock, M., Wakil, A. E., Venkayya, R., Brombacher, F., Rennick, D. M., Sheppard, D., Mohrs, M., Donaldson, D. D., Locksley, R. M., et al. (1998) · Science · doi:10.1126/science.282.5397.2261 · Cited by 1,849
Self-citationZhu, Z., Homer, R. J., Wang, Z., Chen, Q., Geba, G. P., Wang, J., Zhang, Y., & Elias, J. A. (1999) · Journal of Clinical Investigation · doi:10.1172/jci5909 · Cited by 1,719 · cited 1×
“Indeed, the targeted pulmonary expression of IL-13 was shown to cause mucus cell metaplasia, airway fibrosis, and nonspecific airway hyperreactivity (43).”
BackgroundStat6 Is Required for Mediating Responses to IL-4 and for the Development of Th2 Cells
Kaplan, M. H., Schindler, U., Smiley, S. T., & Grusby, M. J. (1996) · Immunity · doi:10.1016/s1074-7613(00)80439-2 · Cited by 1,628 · cited 1×
“In contrast to these observations, granuloma formation and the development of hepatic fibrosis was severely impaired in Stat6-deficient mice (10), which display a major defect in the production of several Th2-associated cytokines (39).”
ResultTwo Improved and Simplified Methods for the Spectrophotometric Determination of Hydroxyproline.
Bergman, I., & Loxley, R. (1963) · Analytical Chemistry · doi:10.1021/ac60205a053 · Cited by 1,525 · cited 1×
“Specifically, hepatic collagen was measured as hydroxyproline by the technique of Bergman and Loxley after hydrolysis of a 200-mg portion of liver in 5 mL of 6 N HCl at 110°C for 18 hours (35).”
MethodDisruption of the murine IL-4 gene blocks Th2 cytokine responses
Kopf, M., Gros, G. L., Bachmann, M., Lamers, M. C., Bluethmann, H., & Köhler, G. (1993) · Nature · doi:10.1038/362245a0 · Cited by 1,203 · cited 2×
“Whereas it is well known that IL-4 is the primary cytokine driving CD4+ Th2 cell development (15, 16), the role of IL-13 in the generation and maintenance of Th2-type responses remains controversial and may be influenced by both host genetics and the infectious disease model under study (24, 27, 29).”
BackgroundLe Gros, G., Ben-Sasson, S. Z., Seder, R., Finkelman, F. D., & Paul, W. E. (1990) · The Journal of experimental medicine · doi:10.1084/jem.172.3.921 · Cited by 954 · cited 2×
“Whereas it is well known that IL-4 is the primary cytokine driving CD4+ Th2 cell development (15, 16), the role of IL-13 in the generation and maintenance of Th2-type responses remains controversial and may be influenced by both host genetics and the infectious disease model under study (24, 27, 29).”
BackgroundPearce, E. J., Caspar, P., Grzych, J. M., Lewis, F. A., & Sher, A. (1991) · The Journal of experimental medicine · doi:10.1084/jem.173.1.159 · Cited by 765
Urban, J. F., Noben-Trauth, N., Donaldson, D. D., Madden, K. B., Morris, S. C., Collins, M., & Finkelman, F. D. (1998) · Immunity · doi:10.1016/s1074-7613(00)80477-x · Cited by 580
Self-citationGrzych, J. M., Pearce, E., Cheever, A., Caulada, Z. A., Caspar, P., Heiny, S., Lewis, F., & Sher, A. (1991) · The Journal of Immunology · doi:10.4049/jimmunol.146.4.1322 · Cited by 542
Self-citation
Cited by
Items 101–200 of 608
Therapeutic Attenuation of Pulmonary Fibrosis Via Targeting of IL-4- and IL-13-Responsive Cells
Jakubzick, C., Choi, E. S., Joshi, B. H., Keane, M. P., Kunkel, S. L., Puri, R. K., & Hogaboam, C. M. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.5.2684 · Cited by 157
Experimental models of Schistosoma mansoni infection
Cheever, A. W., Lenzi, J. A., Lenzi, H. L., & Andrade, Z. A. (2002) · Memórias do Instituto Oswaldo Cruz · doi:10.1590/s0074-02762002000700002 · Cited by 258
“Metwali et al. (1996) found granuloma size to be diminished in IL-4 ko mice but gave a different interpretation to cytokine patterns similar to those reported by Pearce et al. (1996) and Chiramonte et al. (1999b) found enlarged granulomas but decreased fibrosis in IL-4 ko mice.”
BackgroundResultInfluentialSelf-citationErdmann, A. A., Gao, Z.-G., Jung, U., Foley, J., Borenstein, T., Jacobson, K. A., & Fowler, D. H. (2005) · Blood · doi:10.1182/blood-2004-04-1407 · Cited by 149
Mechanisms of Oncostatin M-Induced Pulmonary Inflammation and Fibrosis
Mozaffarian, A., Brewer, A. W., Trueblood, E. S., Luzina, I. G., Todd, N. W., Atamas, S. P., & Arnett, H. A. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.10.7243 · Cited by 153
“IL-13 has been shown to contribute to fibrosis in a variety of models, including hepatic fibrosis induced by schistosome infection (45, 46) and lung fibrosis (47).”
BackgroundTendon healing in interleukin-4 and interleukin-6 knockout mice
Lin, T. W., Cardenas, L., Glaser, D. L., & Soslowsky, L. J. (2005) · Journal of Biomechanics · doi:10.1016/j.jbiomech.2004.11.009 · Cited by 153
Chronic liver injury, TGF-β, and cancer
Bissell, D. M. (2001) · Experimental & Molecular Medicine · doi:10.1038/emm.2001.31 · Cited by 154
“Immunomodulatory cytokines also are being explored as antifibrotic agents: IL-10 (Thompson et al., 1998; Louis et al., 1998; Nelson et al., 2000), IL-12 (Wynn et al., 1995) and antagonists of IL-13 (Chiaramonte et al., 1999; Chiaramonte et al., 2001).”
BackgroundFabre, T., Kared, H., Friedman, S. L., & Shoukry, N. H. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1400861 · Cited by 150
The TNF-family cytokine TL1A promotes allergic immunopathology through group 2 innate lymphoid cells
Meylan, F., Hawley, E. T., Barron, L., Barlow, J. L., Penumetcha, P., Pelletier, M., Sciumè, G., Richard, A. C., Hayes, E. T., Gomez-Rodriguez, J., et al. (2014) · Mucosal Immunology · doi:10.1038/mi.2013.114 · Cited by 149
“During schistosomal infection, host IL-13 drives the granulomatous response that contains parasite eggs in the liver, but also promotes hepatic fibrosis.(36,37) In response to S.”
BackgroundSelf-citationBhattacharya, M., & Ramachandran, P. (2023) · Nature Immunology · doi:10.1038/s41590-023-01551-9 · Cited by 148
Therapeutic Effect of IL-13 Immunoneutralization During Chronic Experimental Fungal Asthma
Blease, K., Jakubzick, C., Westwick, J., Lukacs, N., Kunkel, S. L., & Hogaboam, C. M. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.8.5219 · Cited by 149
“IL-4-transgenic mice do not develop airway fibrosis; however, IL-13-transgenic mice manifest significant degrees of subepithelial and adventitial fibrosis (3, 25, 26).”
BackgroundBrain Granulomas in Neurocysticercosis Patients Are Associated with a Th1 and Th2 Profile
Restrepo, B. I., Alvarez, J. I., Castaño, J. A., Arias, L. F., Restrepo, M., Trujillo, J., Colegial, C. H., & Teale, J. M. (2001) · Infection and Immunity · doi:10.1128/iai.69.7.4554-4560.2001 · Cited by 157
“In this model, the combined role of IL-4 and IL-13 was shown to be essential for the induction of mature granulomas (6).”
Dioscin Exerts Protective Effects Against Crystalline Silica-induced Pulmonary Fibrosis in Mice
Li, C. R., Lu, Y., Du, S., Li, S., Zhang, Y., Liu, F., Chen, Y., Weng, D., & Chen, J. (2017) · Theranostics · doi:10.7150/thno.20270 · Cited by 147
“T helper (Th) cells play a prominent role in the progression of some experimental models of fibrosis [34, 35], and a previous study showed that Th1/Th2 imbalance plays a role in fibrogenesis [36].”
BackgroundImmune Response in Hepatitis B Virus Infection
Tan, A. T., Koh, S., & Bertoletti, A. (2015) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a021428 · Cited by 156
“…IL-10 or TGF-b can have immunoregulatory roles, IL-17- or IL-8-producing T cells can be proinflammatory, whereas Th2 and T cells producing IL-13 have profibrotic effects (Chiaramonte et al. 1999), and cells producing IL-22 have been reported to have hepatoprotective effects (Zenewicz et al. 2007).”
BackgroundTreating very early rheumatoid arthritis
Raza, K., Buckley, C. E., Salmon, M., & Buckley, C. D. (2006) · Best Practice & Research Clinical Rheumatology · doi:10.1016/j.berh.2006.05.005 · Cited by 163
T Lymphocyte-Mediated Liver Immunopathology of Schistosomiasis
Zheng, B., Zhang, J., Chen, H., Nie, H., Miller, H. E., Gong, Q., & Liu, C. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00061 · Cited by 156
“In vitro studies revealed that IL-13 stimulates collagen production in fibroblasts and has a direct role in collagen homeostasis of normal human skin and keloid fibroblasts (40, 41).”
BackgroundPathophysiology of fistula formation in Crohn's disease
Scharl, M. M., & Rogler, G. (2014) · World Journal of Gastrointestinal Pathophysiology · doi:10.4291/wjgp.v5.i3.205 · Cited by 151
Macrophages are critical to the maintenance of IL-13-dependent lung inflammation and fibrosis
Borthwick, L. A., Barron, L., Hart, K. M., Vannella, K. M., Thompson, R. W., Oland, S., Cheever, A., Sciurba, J., Ramalingam, T. R., Fisher, A. J., et al. (2016) · Mucosal Immunology · doi:10.1038/mi.2015.34 · Cited by 138
Self-citationThe role of interleukin-13 in infectious diseases and allergy
Brombacher, F. (2000) · BioEssays · doi:10.1002/1521-1878(200007)22:7<646::aid-bies7>3.0.co;2-9 · Cited by 137
Wilson, M. S., Elnekave, E., Mentink-Kane, M. M., Hodges, M. G., Pesce, J. T., Ramalingam, T. R., Thompson, R. W., Kamanaka, M., Flavell, R. A., Keane-Myers, A., et al. (2007) · Journal of Clinical Investigation · doi:10.1172/jci31546 · Cited by 137
Self-citationScharl, M., Frei, S., Pesch, T., Kellermeier, S., Arikkat, J., Frei, P., Fried, M., Weber, A., Jehle, E., Rühl, A., et al. (2013) · Gut · doi:10.1136/gutjnl-2011-300498 · Cited by 131
Role of Repeated Lung Injury and Genetic Background in Bleomycin-Induced Fibrosis
Chung, M. P., Monick, M. M., Hamzeh, N. Y., Butler, N. S., Powers, L. S., & Hunninghake, G. W. (2003) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2003-0029oc · Cited by 135
Friedman, S. L., Maher, J. J., & Bissell, M. D. (2000) · Hepatology · doi:10.1053/jhep.2000.20243 · Cited by 141
The immunobiology of Th1 polarization in high‐pathology schistosomiasis
Stadecker, M. J., Asahi, H., Finger, E., Hernandez, H. J., Rutitzky, L. I., & Sun, J. (2004) · Immunological Reviews · doi:10.1111/j.0105-2896.2004.00197.x · Cited by 136
“Of great interest is the observation that CD4þ T cells also influence the fibrotic reaction that follows the initial perioval inflammation, which is a complex process mediated, at least in part, by the Th2-type cytokine IL-13 (51, 52).”
BackgroundInfluentialMentink-Kane, M. M., Cheever, A. W., Thompson, R. W., Hari, D. M., Kabatereine, N. B., Vennervald, B. J., Ouma, J. H., Mwatha, J. K., Jones, F. M., Donaldson, D. D., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0305064101 · Cited by 130
Self-citationGieseck, R. L., Ramalingam, T. R., Hart, K. M., Vannella, K. M., Cantu, D. A., Lu, W.-Y., Ferreira-González, S., Forbes, S. J., Vallier, L., & Wynn, T. A. (2016) · Immunity · doi:10.1016/j.immuni.2016.06.009 · Cited by 132
“76 Interleukin-13 (IL-13) has been identified as a major pathogenic cytokine in helminth 77 induced liver disease and several other chronic diseases associated with persistent type-2 78 cytokine production (Chiaramonte et al., 1999).”
Self-citationMechanical force prolongs acute inflammation via T‐cell‐dependent pathways during scar formation
Wong, V. W., Paterno, J., Sorkin, M., Glotzbach, J. P., Levi, K., Januszyk, M., Rustad, K. C., Longaker, M. T., & Gurtner, G. C. (2011) · The FASEB Journal · doi:10.1096/fj.10-178087 · Cited by 126
“dent skin fibrosis (12) and suggest a more important role for IL-13 as compared with IL-4 in fibrogenesis, as has been previously demonstrated in a mouse model of liver fibrosis (49).”
BackgroundHe, C., Ryan, A. J., Murthy, S., & Carter, A. B. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.410720 · Cited by 128
“Studies have linked the role of Th2 cytokines and alternatively activated macrophages in fibrotic disease development (26, 27); however, it is not known whether a Th2 cytokineindependent pathway can lead to the development of fibrosis.”
BackgroundElevations in IL-10, TNF- α , and IFN- γ from the Earliest Point of HIV Type 1 Infection
Norris, P. J., Pappalardo, B. L., Custer, B., Spotts, G. E., Hecht, F. M., & Busch, M. P. (2006) · AIDS Research and Human Retroviruses · doi:10.1089/aid.2006.22.757 · Cited by 131
Weng, H.-L., Liu, Y., Chen, J.-L., Huang, T., Xu, L.-J., Godoy, P., Hu, J.-H., Zhou, C., Stickel, F., Marx, A., et al. (2009) · Hepatology · doi:10.1002/hep.22934 · Cited by 129
Stäger, S., Alexander, J. K., Carter, K. C., Brombacher, F., & Kaye, P. M. (2003) · Infection and Immunity · doi:10.1128/iai.71.8.4804-4807.2003 · Cited by 130
“IL-13, in contrast to IL-4, has been shown to have a major role in the regulation of collagen synthesis in granulomas induced by Schistosoma mansoni eggs (6).”
BackgroundRedundant and Pathogenic Roles for IL-22 in Mycobacterial, Protozoan, and Helminth Infections
Wilson, M. S., Feng, C. G., Barber, D. L., Yarovinsky, F., Cheever, A. W., Sher, A., Grigg, M. E., Collins, M. A., Fouser, L. A., & Wynn, T. A. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0903416 · Cited by 142
Self-citationT cell contributions to the different phases of granuloma formation
Co, D. O., Hogan, L. H., Il-Kim, S., & Sándor, M. (2004) · Immunology Letters · doi:10.1016/j.imlet.2003.11.023 · Cited by 129
Weng, S.-Y., Wang, X., Vijayan, S., Tang, Y., Kim, Y. O., Padberg, K., Regen, T., Molokanova, O., Chen, T., Bopp, T., et al. (2018) · EBioMedicine · doi:10.1016/j.ebiom.2018.01.028 · Cited by 128
“, 1992) or T cells (Cheever et al., 1994; Chiaramonte et al., 1999) that can respond to IL-4 and IL-13, such as mast cells (Nilsson and Nilsson, 1995; Ochi et al.”
BackgroundResultInfluentialHoffmann, K. F., Wynn, T. A., & Dunne, D. W. (2002) · Advances in Parasitology/Advances in parasitology · doi:10.1016/s0065-308x(02)52014-5 · Cited by 135
Self-citationHuman basophils: mediator release and cytokine production
Schroeder, J. T., MacGlashan, D. W., & Lichtenstein, L. M. (2001) · Advances in immunology · doi:10.1016/s0065-2776(01)77015-0 · Cited by 136
Vaillant, B., Chiaramonte, M. G., Cheever, A. W., Soloway, P. D., & Wynn, T. A. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.12.7017 · Cited by 123
“cytokines that promote fibrosis in this disease (5, 6).”
BackgroundSelf-citationLee, P. J. (2005) · Journal of Clinical Investigation · doi:10.1172/jci25711 · Cited by 123
Interleukin 13 and its role in gut defence and inflammation
Mannon, P., & Reinisch, W. (2012) · Gut · doi:10.1136/gutjnl-2012-303461 · Cited by 133
The Pathophysiology of Thyroid Eye Disease
Shan, S. J. C., & Douglas, R. S. (2014) · Journal of Neuro-Ophthalmology · doi:10.1097/wno.0000000000000132 · Cited by 129
Pathogenesis of Kupffer Cells in Cholestatic Liver Injury
Sato, K., Hall, C. M., Glaser, S. S., Francis, H., Meng, F., & Alpini, G. D. (2016) · American Journal Of Pathology · doi:10.1016/j.ajpath.2016.06.003 · Cited by 126
Interleukins in chronic liver disease: lessons learned from experimental mouse models
Tacke, F., & Hammerich, L. (2014) · Clinical and Experimental Gastroenterology · doi:10.2147/ceg.s43737 · Cited by 120
“39–41 IL-13-deficient mice or mice treated with an IL-13 inhibitor developed significantly less liver fibrosis than mice with intact IL-13 signaling.”
Everts, B., Tussiwand, R., Dreesen, L., Fairfax, K. C., Huang, S. C.-C., Smith, A. M., O’Neill, C. M., Lam, W. Y., Edelson, B. T., Urban, J. F., et al. (2016) · Journal of Experimental Medicine · doi:10.1084/jem.20150235 · Cited by 117
Association of Type 2 Cytokines with Hepatic Fibrosis in HumanSchistosoma mansoniInfection
de Jesus, A. R., Magalhães, A. S., Miranda, D. G., Miranda, R. G., Araújo, M. I., de Jesus, A. A., Silva, Â., Santana, L. B., Pearce, E. J., & Carvalho, E. M. (2004) · Infection and Immunity · doi:10.1128/iai.72.6.3391-3397.2004 · Cited by 120
IL-4 induces IL-13–independent allergic airway inflammation
Perkins, C. L., Wills-Karp, M. A., & Finkelman, F. D. (2006) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2006.06.004 · Cited by 131
Lurje, I., Hammerich, L., & Tacke, F. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21197378 · Cited by 126
“of liver fibrosis [69], but also to the immunological control of the parasite [70,71].”
BackgroundTherapeutic Targeting of IL-4- and IL-13-Responsive Cells in Pulmonary Fibrosis
Jakubzick, C., Kunkel, S. L., Puri, R. K., & Hogaboam, C. M. (2004) · Immunologic Research · doi:10.1385/ir:30:3:339 · Cited by 123
“IL-13 had recently joined the ranks of immunomodulatory cytokines that exert major profibrotic effects in the lung (27,33–36) and liver ( 37 ,38).”
BackgroundHesse, M., Cheever, A. W., Jankovic, D. L., & Wynn, T. A. (2000) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64607-x · Cited by 117
“Previous studies demonstrated that the type-2-associated cytokines IL-4 and IL-13 are the critical mediators of egg-induced inflammation and fibrosis in infected WT mice.(4,5,21) However, the data presented here suggest that significant inflammation and fibrosis can also accompany highly polarized type-1 immune respon…”
BackgroundResultSelf-citationCytokines and STATs in Liver Fibrosis
Kong, X., Horiguchi, N., Mori, M., & Gao, B. (2012) · Frontiers in Physiology · doi:10.3389/fphys.2012.00069 · Cited by 113
“…liver fibrosis as the reduction in fibrosis observed in IL-4-deficient mice was much less pronounced than that in sIL-13Ralpha2-Fc-treated animals (Chiaramonte et al., 1999a,b; Fallon et al., 2000) Both IL-4 and IL-13 predominately induce STAT6 activation in HSCs. Blockage of STAT6 with siRNA…”
BackgroundGranulomas in schistosome and mycobacterial infections: a model of local immune responses
Sándor, M., Weinstock, J. V., & Wynn, T. A. (2002) · Trends in Immunology · doi:10.1016/s1471-4906(02)00006-6 · Cited by 131
Braga, T. T., Correa-Costa, M., Guise, Y. F. S., Castoldi, A., de Oliveira, C. D., Hyane, M. I., Cenedeze, M. A., Teixeira, S. A., Muscara, M. N., Perez, K. R., et al. (2012) · Molecular Medicine · doi:10.2119/molmed.2012.00131 · Cited by 111
Opposing roles for IL‐13 and IL‐13 receptor α2 in health and disease
Mentink‐Kane, M. M., & Wynn, T. A. (2004) · Immunological Reviews · doi:10.1111/j.0105-2896.2004.00210.x · Cited by 114
“Liver fibrosis decreased over 85% when WT mice were treated with sIL-13Ra2-Fc (20).”
BackgroundMethodInfluentialSelf-citationVannella, K. M., Barron, L., Borthwick, L. A., Kindrachuk, K. N., Narasimhan, P. B., Hart, K. M., Thompson, R. W., White, S., Cheever, A. W., Ramalingam, T. R., et al. (2014) · PLoS Pathogens · doi:10.1371/journal.ppat.1004372 · Cited by 111
Self-citationMa, B., Zhu, Z., Homer, R. J., Gerard, C., Strieter, R., & Elias, J. A. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.3.1872 · Cited by 108
“However, recent studies from our laboratory and others demonstrated that IL-13 is also a powerful regulator of tissue remodeling in vivo and in vitro (4, 13).”
BackgroundLiu, Y., Meyer, C., Müller, A., Herweck, F., Li, Q., Müllenbach, R., Mertens, P. R., Dooley, S., & Weng, H.-L. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1003260 · Cited by 111
The Role of an IL-10/Hyaluronan Axis in Dermal Wound Healing
Singampalli, K. L., Balaji, S., Wang, X., Parikh, U. M., Kaul, A., Gilley, J., Birla, R. K., Bollyky, P. L., & Keswani, S. G. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00636 · Cited by 125
Chizzolini, C. (2008) · Current Opinion in Rheumatology · doi:10.1097/bor.0b013e32830c45ae · Cited by 114
Obesity: An Immunometabolic Perspective
Ray, I., Mahata, S. K., & De, R. K. (2016) · Frontiers in Endocrinology · doi:10.3389/fendo.2016.00157 · Cited by 119
“Thus, IL-13 produced by Th2 CD4+ T cells (52, 60, 61) and TGFβ1 activate fibroblasts to differentiate into α-smooth muscle actin (α-SMA) expressing myofibroblasts to produce ECM (62–64).”
BackgroundKomai, M., Tanaka, H., Masuda, T., Nagao, K., Ishizaki, M., Sawada, M., & Nagai, H. (2003) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705105 · Cited by 107
“This e ect was assumed to be due to the direct e ects of IL-13 on ®broblasts since IL-13 stimulates ®broblast proliferation and collagen production in vitro (Chiaramonte et al., 1999; Doucet et al., 1998).”
BackgroundQuantitative Assessment of Macrophage Functions in Repair and Fibrosis
Wynn, T. A., Barron, L., Thompson, R. W., Madala, S. K., Wilson, M. S., Cheever, A. W., & Ramalingam, T. (2011) · Current Protocols in Immunology · doi:10.1002/0471142735.im1422s93 · Cited by 102
Self-citationInterleukin-13 in asthma pathogenesis
Wills-Karp, M. A. (2004) · Current Allergy and Asthma Reports · doi:10.1007/s11882-004-0057-6 · Cited by 147
“A clear demarcation of function for IL-4 and IL-13 in fibrosis has been demonstrated in Th2-mediated pathology of S. mansoni infection in which sIL-13Rα2-Ig delivery completely prevented parasiteinduced fibrosis [ 36 ].”
BackgroundRole of Early Growth Response-1 (Egr-1) in Interleukin-13-induced Inflammation and Remodeling
Cho, S. J., Kang, M., Homer, R., Kang, H., Zhang, X., Lee, P. J., Elias, J. A., & Lee, C. G. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m506770200 · Cited by 113
Immune Interactions in Hepatic Fibrosis
Holt, A. P., Salmon, M., Buckley, C. D., & Adams, D. H. (2008) · Clinics in Liver Disease · doi:10.1016/j.cld.2008.07.002 · Cited by 101
“CD41 T cells were found to secrete a fibrotic factor in a Th2-polarized mouse model of liver fibrosis, which was subsequently shown to be IL-13.(132,133) The polarity of the inflammatory response is critical for fibrogenesis, and different programs of gene expression are induced when chronic inflammatory responses are”
Hoffmann, K. F., McCarty, T. C., Segal, D. H., Chiaramonte, M., Hesse, M., Davis, E. M., Cheever, A. W., Meltzer, P. S., III, H. C. M., & Wynn, T. A. (2001) · The FASEB Journal · doi:10.1096/fj.01-0306fje · Cited by 102
“Our S understanding of schistosomiasis-related liver pathology is limited to the immunologically mediated phase induced by the Th2-asociated cytokines interleukin-4 (IL-4) (3–6), transforming GF- (7), and IL-13 (8, 9) and inhibited by the Th1-associated cytokines - (10–12) and IL-12 (13, 14).”
BackgroundSelf-citationWilson, M. S., Ramalingam, T. R., Rivollier, A., Shenderov, K., Mentink–Kane, M. M., Madala, S. K., Cheever, A. W., Artis, D., Kelsall, B. L., & Wynn, T. A. (2011) · Gastroenterology · doi:10.1053/j.gastro.2010.09.047 · Cited by 101
Self-citationT lymphocytes as critical mediators in tissue regeneration, fibrosis, and the foreign body response
Adusei, K. M., Ngo, T. B., & Sadtler, K. (2020) · Acta Biomaterialia · doi:10.1016/j.actbio.2021.04.023 · Cited by 109
Park, S.-W., Ahn, M.-H., Jang, H. K., Jang, A. S., Kim, D.-J., Koh, E.-S., Park, J.-S., Uh, S.-T., Kim, Y. H., Park, J. S., et al. (2009) · Journal of Korean Medical Science · doi:10.3346/jkms.2009.24.4.614 · Cited by 97
“IL-13 may induce pulmonary fibrosis directly (25) or indirectly through TGF (beta)-1 (26) and several types of MMP (27).”
BackgroundThe Role of Mesenchymal Stem Cells in Radiation-Induced Lung Fibrosis
Zanoni, M., Cortesi, M., Zamagni, A., & Tesei, A. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20163876 · Cited by 102
“IL-13 is the predominant regulator of fibrotic tissue remodeling in several models of fibrosis [61] such as idiopathic pulmonary fibrosis (IPF) [62] and radiation-induced fibrosis [63].”
BackgroundNovel PPARγ Modulator GED-0507-34 Levo Ameliorates Inflammation-driven Intestinal Fibrosis
Speca, S., Rousseaux, C., Dubuquoy, C., Rieder, F., Vetuschi, A., Sferra, R., Giusti, I., Bertin, B., Dubuquoy, L., Gaudio, E., et al. (2015) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000000618 · Cited by 101
Fattouh, R., Midence, N. G., Arias, K., Johnson, J. R., Walker, T. D., Goncharova, S., Souza, K. P., Gregory, R. C., Lonning, S., Gauldie, J., et al. (2008) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200706-958oc · Cited by 96
“Notably, IL-13, a prototypical Th2associated cytokine, was shown to be an indispensable mediator of hepatic fibrosis in this model ( 52 ).”
IL-13 Signaling in Liver Fibrogenesis
Liu, Y., Munker, S., Müllenbach, R., & Weng, H.-L. (2012) · Frontiers in Immunology · doi:10.3389/fimmu.2012.00116 · Cited by 91
“Subsequently three hallmark studies compared the role of IL-4 and IL-13 in granuloma formation and liver fibrosis of S. mansoni infected mice (Chiaramonte et al., 1999a,b; Fallon et al., 2000).”
BackgroundInfluentialJinnin, M., Ihn, H., Yamane, K., & Tamaki, K. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m406951200 · Cited by 106
Immune cells in repair of the infarcted myocardium
Chen, B., & Frangogiannis, N. G. (2017) · Microcirculation · doi:10.1111/micc.12305 · Cited by 103
Regulation of Fibrosis by the Immune System
Lupher, M., & Gallatin, W. M. (2006) · Advances in immunology · doi:10.1016/s0065-2776(05)89006-6 · Cited by 101
McDermott, J. R., Humphreys, N. E., Forman, S. P., Donaldson, D. D., & Grencis, R. K. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.5.3207 · Cited by 93
“known to induce liver fibrosis in schistosomiasis (25), and is a”
BackgroundSelf-citationEfficacy of non-invasive elastometry on staging of hepatic fibrosis
Saito, H. (2004) · Hepatology Research · doi:10.1016/j.hepres.2004.03.007 · Cited by 93
“The major source of fibrogenesis is hepatic stellate cells (Ito cells), which transform from fat storing cells to fibroblasts and proliferate by some cytokines, such as transforming growth factor (TGF)- [2], interleukin-13 [3], hepatocyte growth factor or angiotensin II [4,5].”
BackgroundCombatting Fibrosis: Exosome‐Based Therapies in the Regression of Liver Fibrosis
Chen, L., Brenner, D. A., & Kisseleva, T. (2019) · Hepatology Communications · doi:10.1002/hep4.1290 · Cited by 91
CD4+ T Cells Regulate Surgical and Postinfectious Adhesion Formation
Chung, D. R., Chitnis, T., Panzo, R. J., Kasper, D. L., Sayegh, M. H., & Tzianabos, A. O. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20020028 · Cited by 91
Cripps, J. G., Wang, J., Maria, A., Blumenthal, I., & Gorham, J. D. (2010) · Hepatology · doi:10.1002/hep.23841 · Cited by 91
“Murine liver schistosomiasis is a classic model of Th2-mediated inflammation, with granulomata forming around parasite eggs deposited in the liver.(24,25) Myeloid cells restrain granulomatous inflammation and fibrosis through activity of arginase,(26) which acts by depleting T cells of the essential amino acid L-argin…”
BackgroundKamal, S. M., Graham, C. S., He, Q., Bianchi, L., Tawil, A. A., Rasenack, J. W. F., Khalifa, K., Massoud, M., & Koziel, M. J. (2004) · The Journal of Infectious Diseases · doi:10.1086/382278 · Cited by 91
Rutitzky, L. I., Hernández, H. J., & Stadecker, M. J. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.231258498 · Cited by 90
Mononuclear cells in liver fibrosis
Marra, F., Aleffi, S., Galastri, S., & Provenzano, A. (2009) · Seminars in Immunopathology · doi:10.1007/s00281-009-0169-0 · Cited by 90
“While IL-4 and IL-13 play redundant roles in granuloma formation, IL-13 was found to be the dominant Th2-type cytokine for the induction of fibrosis, as it stimulated collagen production in fibroblasts, and treatment with a soluble form of the IL-13 receptor resulted in reduced expression of extracellular matrix [83].”
BackgroundLOCALIZATION OF HUMAN INTERLEUKIN 13 RECEPTOR IN NON-HAEMATOPOIETIC CELLS
Akaiwa, M., Yu, B., Suyama, R., Terada, N., Suto, H., Koga, T., Arima, K., Matsushita, S., Saito, H., Ogawa, H., et al. (2001) · Cytokine · doi:10.1006/cyto.2000.0814 · Cited by 103
MacDonald, A. S., Patton, E. A., Flamme, A. C. L., Araújo, M. I., Huxtable, C. R. R., Bauman, B. E., & Pearce, E. J. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.9.4643 · Cited by 89
“It has previously been shown that IL-4 and IL-13 play important roles in granuloma formation and development of fibrosis during schistosome infection (11, 34).”
BackgroundThe role of immune cells in atrial fibrillation
Liu, Y., Shi, Q., Ma, Y., & Liu, Q. (2018) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2018.09.007 · Cited by 97
The Role of Interleukin 13 in Classical Hodgkin Lymphoma
Skinnider, B., Kapp, U., & Mak, T. W. (2002) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/10428190290026259 · Cited by 97
“IL-13 also acts directly on fibroblasts, and has been shown to mediate fibrosis in allergic asthma and Schistosoma mansoni-induced hepatic fibrosis [23,24].”
BackgroundEffect of IL‐4 and IL‐13 on collagen production in cultured LI90 human hepatic stellate cells
Sugimoto, R., Enjoji, M., Nakamuta, M., Ohta, S., Kohjima, M., Fukushima, M., Kuniyoshi, M., Arimura, E., Morizono, S., Kotoh, K., et al. (2005) · Liver International · doi:10.1111/j.1478-3231.2005.01087.x · Cited by 91
“A direct role for IL-13 in hepatic fibrosis during murine schistosome infection has been demonstrated (38, 39).”
BackgroundLiu, W. (2010) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2010.10.004 · Cited by 100
IL-13 mediates collagen deposition via STAT6 and microRNA-135b: a role for epigenetics
O’Reilly, S., Ciechomska, M., Fullard, N., Przyborski, S., & van Laar, J. M. (2016) · Scientific Reports · doi:10.1038/srep25066 · Cited by 86
Phase 2 trial to assess lebrikizumab in patients with idiopathic pulmonary fibrosis
Maher, T. M., Costabel, U., Glassberg, M. K., Kondoh, Y., Ogura, T., Scholand, M. B., Kardatzke, D., Howard, M., Olsson, J., Neighbors, M., et al. (2021) · European Respiratory Journal · doi:10.1183/13993003.02442-2019 · Cited by 79
“Interleukin (IL)-13 is a potent activator of fibroblasts, promoting extracellular matrix synthesis with potential pathogenic roles in fibrosis [7 – 10].”
IL-13 Receptor α2 Selectively Inhibits IL-13-Induced Responses in the Murine Lung
Zheng, T., Liu, W., Oh, S.-Y., Zhu, Z., Hu, B., Homer, R. J., Cohn, L., Grusby, M. J., & Elias, J. A. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.1.522 · Cited by 86
“These findings appear to conflict with our findings and those by others in murine schistosomiasis models (38, 42, 57) that IL13R 2 inhibits TGF- 1 production and tissue fibrosis.”
BackgroundResultReview: Frontiers of Antifibrotic Therapy in Systemic Sclerosis
Distler, J. H. W., Feghali‐Bostwick, C., Soare, A., Asano, Y., Distler, O., & Abraham, D. J. (2017) · Arthritis & Rheumatology · doi:10.1002/art.39865 · Cited by 82
“IL-13–targeting therapies were shown to attenuate experimental pulmonary and hepatic fibrosis (31,32).”
BackgroundCitrin, D. E., Prasanna, P. G. S., Walker, A. J., Freeman, M. L., Eke, I., Barcellos‐Hoff, M. H., Arankalayil, M. J., Cohen, E. P., Wilkins, R. C., Ahmed, M. M., et al. (2017) · Radiation Research · doi:10.1667/rr14784.1 · Cited by 96
Self-citationCationic Amino Acid Transporter-2 Regulates Immunity by Modulating Arginase Activity
Thompson, R. W., Pesce, J. T., Ramalingam, T., Wilson, M. S., White, S., Cheever, A. W., Ricklefs, S. M., Porcella, S. F., Li, L., Ellies, L. G., et al. (2008) · PLoS Pathogens · doi:10.1371/journal.ppat.1000023 · Cited by 85
“mice developed granulomas that were 3- to 4-times larger than WT and hepatic fibrosis (a feature of severe disease) was significantly exacerbated in chronically infected mice”
BackgroundSelf-citationAn Overview of Hedgehog Signaling in Fibrosis
Hu, L., Lin, X., Lu, H., Chen, B., & Bai, Y. (2014) · Molecular Pharmacology · doi:10.1124/mol.114.095141 · Cited by 88
“Type II noncanonical signaling operates via Smo functions beyond Gli regulation (Chinchilla et al., 2010; Polizio et al., 2011; Brennan et al., 2012).”
BackgroundJohnson, T. R., Parker, R. A., Johnson, J. E., & Graham, B. S. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.4.2037 · Cited by 90
Advances in antifibrotic therapy
Ghiassi–Nejad, Z., & Friedman, S. L. (2008) · Expert Review of Gastroenterology & Hepatology · doi:10.1586/17474124.2.6.803 · Cited by 88
CD4+CD25+Foxp3+ regulatory T cells suppress cardiac fibrosis in the hypertensive heart
Kanellakis, P., Dinh, T. N., Agrotis, A., & Bobik, A. (2011) · Journal of Hypertension · doi:10.1097/hjh.0b013e328349c62d · Cited by 83
Protection and pathology during parasite infection: IL ‐10 strikes the balance
Redpath, S. A., Fonseca, N. M., & Perona‐Wright, G. (2014) · Parasite Immunology · doi:10.1111/pim.12113 · Cited by 97
“cytokines IL-4, IL-5 and IL-13 promote granulomatous fibrosis, which acts to isolate and neutralise the toxic products of the parasite eggs (95, 96) and to suppress the development of”
BackgroundIngram, J. L., Rice, A. B., Geisenhoffer, K., Madtes, D. K., & Bonner, J. C. (2004) · The FASEB Journal · doi:10.1096/fj.03-1492fje · Cited by 89
Hasegawa, M., Sato, S., Nagaoka, T., Fujimoto, M., & Takehara, K. (2003) · Dermatology · doi:10.1159/000071783 · Cited by 89
Metadata
- Authors
- Chiaramonte, M. G., Donaldson, D. D., Cheever, A. W., & Wynn, T. A.
- Affiliations
- National Institutes of Health (US)
- Biomedical Research Institute (US)
- Corresponding author
- Wynn, Thomas A.
- ORCID
- Wynn, Thomas A.
- Venue
- Journal of Clinical Investigation
- Published
- 1999-09-15
- Volume
- 104
- Issue
- 6
- Pages
- 777-785
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC408441
- OpenAlex
- W1975021657
- Cited by
- 603
- References
- 47
- Citations by year
- 2026: 4 · 2025: 11 · 2024: 7 · 2023: 8 · 2022: 14 · 2021: 16 · 2020: 21 · 2019: 13 · 2018: 34 · 2017: 18 · 2016: 30 · 2015: 28 · 2014: 35 · 2013: 23 · 2012: 30
- FWCI
- 19.21
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Parasitology › Parasites and Host Interactions
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Life Sciences › Immunology and Microbiology › Immunology › IL-33, ST2, and ILC Pathways
- Keywords
- IL-13, liver fibrosis, schistosomiasis, Schistosoma mansoni, Th2 cytokines, IL-4, granuloma formation, collagen synthesis, fibroblasts, procollagen mRNA, antifibrotic therapy
- MeSH terms
- Animals, Female, Liver, Liver Cirrhosis, Experimental, Mice, Inbred C57BL, Procollagen, RNA, Messenger, Schistosomiasis mansoni, Interleukin-4, Cytokines, 3T3 Cells, Mice, Knockout, Th1 Cells, Th2 Cells, Interleukin-13, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.